Alejandro I. D. R.
- Country
- Spain
- Department
- Neurology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
- A Randomized, Double‑Blind, Placebo‑Controlled Study of TAK‑360 for Safety, Tolerability, and Efficacy in Adults with Narcolepsy Type 1 (Cataplexy)
Data & Insights
Has run more than one trial at 48 of 61 partner sites.
Specializations
Sleep Disorders
This investigator specializes in the study and treatment of narcolepsy, with particular focus on both Type 1 and Type 2 variants of the condition.
- Narcolepsy with Cataplexy (Type 1)
- Narcolepsy Type 2
- Excessive Daytime Sleepiness (EDS)
The research encompasses comprehensive evaluation of therapeutic interventions for narcolepsy management.
Therapeutic Assessment
Focuses on evaluating novel therapeutic approaches for sleep disorder management, particularly in the context of long-term safety and effectiveness.
- Safety and Tolerability Studies
- Long-term Treatment Outcomes
- Clinical Efficacy Assessment
Conducts systematic evaluation of treatment responses using standardized measurement tools such as the Epworth Sleepiness Scale.
Clinical Expertise
Demonstrates specialized knowledge in neurological sleep disorders and their therapeutic management.
- Sleep Disorder Therapeutics
- Novel Treatment Approaches
- Patient Response Monitoring
Maintains active involvement in the development and assessment of innovative treatments for sleep disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.